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Abstract
Background: Infection caused by Streptococcus agalactiae, a Group B streptococcus, is an emerging disease in
non-pregnant adults. This study describes the epidemiological, clinical, and microbiological characteristics of S.
agalactiae infection in adult patients in northern Thailand.
Methods: A retrospective study was conducted between January 1, 2006 and December 31, 2009 at Chiang Mai
University Hospital among patients aged ≥15 years, whose clinical specimens obtained from normally sterile sites
grew S. agalactiae.
Results: One-hundred and eighty-six patients and 197 specimens were identified during the 4-year period. Among
186 patients, 82 were documented as having invasive infection; 42 patients were male (51.2%) with the mean age
of 48.5 ± 19.4 years (range 17, 83). Fifty-three patients (64.6%) had underlying medical conditions; 17 patients
(20.7%), 10 (12.2%), 8 (9.7%) had diabetes, chronic renal diseases, and malignancy, respectively. Among 40 patients
(48.8%) with bloodstream infection, no other site of infection was determined in 29 (35.4%) patients. In the
remaining 11 patients, 5 patients (6.1%), 5 (6.1%), and 1 (1.2%) had meningitis, arthritis, and meningitis with
arthritis, respectively. Forty-two patients (51.2%) presented with localized infection, i.e., subcutaneous abscess (19
patients, 23.2%), chorioamnionitis (10 patients, 12.2%), urinary tract infection (5 patients, 6.1%), arthritis (3 patients,
3.7%), meningitis (2 patients, 2.4%), and spontaneous bacterial peritonitis, uveitis, and tracheobronchitis (1 patient
each, 1.2%). The overall mortality was 14.6% (12 patients).
Conclusions: S. agalactiae infection is a growing problem in non-pregnant patients, particularly in those with
underlying medical conditions. Physicians should add S. agalactiae infection in the list of differential diagnoses in
patients with meningitis and/or septicemia.
Background
Streptococcus agalactiae, a group B, b-hemolytic strepto-
coccus, is a well-known cause of postpartum infection
and neonatal sepsis[1,2]. It colonizes in the gastrointest-
inal and urinary tract in healthy adults as well as the
genital tract in healthy women[1,2]. Recently, the num-
ber of cases of invasive infection caused by S. agalactiae
in non-pregnant adults is increasing; [2-10] the majority
of patients had underlying medical conditions including
diabetes, malignancy, genitourinary abnormalities, neu-
rologic deficits, cirrhosis, renal dysfunction, steroid uses,
and AIDS[2,3,6-8,11]. Clinical manifestations of invasive
S. agalactiae infection vary widely depending on the
sites of infection. Primary bacteremia without any
obvious source is a common presentation in non-preg-
nant adults[2,3,6,7,10]. Endocarditis and meningitis have
also been observed[3,6-9]. A myriad of virulence factors
are crucial for its ability to cause invasive disease; these
include but are not limited to the pore-forming toxins
and the sialic acid-rich capsular polysaccharide[12,13].
The mortality rate ranges from 3-47% and is highest in
elderly patients with underlying medical conditions
[2,3,5,6,8-10]. This study aimed to describe the epide-
miological, clinical, and microbiological data of invasive
S. agalactiae infection in adult patients admitted to
Chiang Mai University Hospital, a tertiary care center in
Northern Thailand. * Correspondence: rchaiwar@gmail.com
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Study design and population
A retrospective study was conducted among patients
aged ≥15 years whose clinical specimens obtained from
sterile sites grew S. agalactiae. The study was conducted
between January 1, 2006 and December 31, 2009 at
Chiang Mai University Hospital, an 1800-bed, tertiary-
care hospital in Northern Thailand. Clinical data were
retrospectively collected using a preprinted data collec-
tion form.
Definitions
Colonization was defined as the isolation of microor-
ganisms from clinical specimens other than blood with-
out clinical signs or symptoms[14].
Infection was defined as the isolation of microorgan-
isms from sterile sites accompanying clinical signs and
symptoms[14].
Specimens from sterile sites included blood, cere-
brospinal fluid (CSF), and body fluid or pus taken from
normally sterile sites such as joint, chorioamniotic fluid,
urine, and peritoneal fluid.
Microbiological methods
The blood agar subcultures from clinical specimen after
24-hour incubation at 35 to 37°C in 5% CO2 atmosphere
were determined for group B streptococci (S. agalactiae).
Agar plates with visible microorganism growth were
observed for large, gray, translucent colonies with a nar-
row or no zone of beta-hemolysis, gram-positive cocci in
pairs and chains. The biochemical method was used to
identify the species of group B streptococci[15-17].
Antimicrobial susceptibility test was performed by
agar disk diffusion method according to the Clinical and
Laboratory Standards Institute (CLSI)[18]. Susceptibility
testing for penicillin, ampicillin, levofloxacin, tetracy-
cline, and vancomycin was routinely performed; suscept-
ibility to ceftriaxone and cefotaxime was done upon
request by attending physicians. All the identification
and susceptibility procedu r e sw e r ep e r f o r m e da tt h e
central diagnostic laboratory, Chiang Mai University
hospital. These methods were not changed during the
study period.
The study was approved by the Faculty of Medicine,
Chiang Mai University Ethical Committee.
Statistical analysis
Clinical data were presented in numbers (%); mean and
standard deviation (SD); and median and interquartile
range (IQR) as appropriate. Comparisons of demo-
graphic data and clinical characteristics between groups
of patients who survived vs. those who died were per-
formed using Student’s t-test, Mann-Whitney U test,
Chi-square test or Fisher’s exact test as appropriate.
Univariate analysis was performed to determine predict-
ing factors for fatal outcome. Variables with p-value <
0.10 from the univariable analysis were then tested in
multivariable models. A two-sided test at a p-value of <
0.05 was used to indicate statistical significance. All sta-
tistical analyses were performed using Stata statistical
software version 10.0 (Stata Statistical Software: Release
10.0, Stata Corporation, College Station, TX, 2007).
Results
Demographic data
One hundred and eighty-six patients and 197 specimens
were identified during the 4-year period; the numbers of
cases each year were 24, 56, 45, and 61, respectively.
T h e r ew e r ec o n s i d e r a b l ym o r ec a s e si nS e p t e m b e ra s
s h o w ni nF i g u r e1 .A m o n gt h e1 8 6p a t i e n t s ,8 2w e r e
determined as having invasive S. agalactiae infection
whereas 104 patients having S. agalactiae colonization.
From the total of 186 patients, 84 were males (45.2%)
and the median age was 52 years (IQR 41, 66). One
hundred and twenty-three patients (66.1%) had underly-
ing diseases including diabetes (38 patients, 20.4%), non-
hematologic malignancy (27 patients, 14.5%), hematolo-
gic malignancy (8 patients, 4.3%), chronic kidney dis-
eases (21 patients, 9.1%), cirrhosis (2 patients, 1.1%),
thalassemia (2 patients, 1.1%), and neurogenic bladder
(1 patient, 0.5%). There were 12 pregnant women
(6.5%); 4 patients (2.2%), 1 (1.1%), and 7 (3.8%) were in
the first, second, and third trimester, respectively.
The types of clinical isolates were urine (79 patients),
pus from sterile sites (41), blood (40), chorioamniotic
fluid (10), sputum (9), CSF (8), joint fluid (8), peritoneal
fluid (1), and vitreous (1). Isolation of S. agalactiae from
multiple sites was observed in some patients, i.e., from
blood and CSF (5 patients), from blood and joint fluid
Number of patients
Month
Figure 1 Number of patients infected or colonized with S.
agalactiae in 2006, 2007, 2008, and 2009 by month.
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Page 2 of 7(5 patients), and from blood, CSF, and joint fluid (1
patient).
Among the 82 patients with invasive S. agalactiae
infection, the numbers of cases were 6, 23, 20, and 33 in
2006, 2007, 2008, and 2009, respectively. Forty-two
patients (51.2%) were male and the median age was 50
years (IQR 29, 63).
Clinical data
Among 82 patients who had invasive S. agalactiae infec-
tion, 40 patients (48.8%) presented with bloodstream
infection. No other site of infection was determined in
29 (35.4%) of these 40 patients. In the remaining 11
patients, 5 patients (6.1%), 5 (6.1%), and 1 (1.2%) had
meningitis, arthritis, and meningitis with arthritis,
respectively. Forty-two patients (51.2%) presented with
localized infection, i.e., subcutaneous abscess (19
patients, 23.2%), chorioamnionitis (10 patients, 12.2%),
urinary tract infection (5 patients, 6.1%), arthritis (3
patients, 3.7%), meningitis (2 patients, 2.4%), and spon-
taneous bacterial peritonitis, uveitis, and tracheobronchi-
tis (1 patient each, 1.2%).
Of the 8 patients who had meningitis, all had fever, 5
had headache, and 4 had altered mentation. The mean
open pressure and close pressure when lumbar puncture
was performed were 27.8 ± 6.4 and 22.8 ± 6.1 cm, respec-
tively. The mean CSF protein was 538.1 ± 419.9 mg/dL
and the mean CSF glucose was 26.1 ± 24.2 mg/dL.
Of the 8 patients who had arthritis, 6 had fever. All
patients had monoarthritis including knee (2 patients),
ankle (2 patients), hip (2 patients), shoulder (1 patient),
and distal interphalangeal joint (1 patient). Joint fluid
analysis was not done in 5 patients. The white blood
cell counts in joint fluid from 3 patients were 17,800
(neutrophil 83%), 30,800 (neutrophil 100%), and 98,000
cells/mm
3 (neutrophil 96%).
All 5 patients with urinary tract infection had fever
and pyuria. The white blood cells in urine were 50-100
cells/high power field (HPF). Chorioamnionitis was diag-
nosed in 10 pregnant women; 2 were in first trimester, 1
was in second trimester, and 7 were in third trimester of
pregnancy. Six patients presented with premature rup-
ture of membranes, 2 patients had abdominal pain after
non-medical abortion, and 1 patient presented with fetal
death in utero.
The demographic data and clinical characteristics were
shown in Table 1.
All clinical isolates were sensitive to penicillin, ampi-
cillin, levofloxacin, and vancomycin. All isolates were
resistant to tetracycline. All patients who had infection
received antimicrobial therapy; 40, 12, 6, and 6 patients
received ceftriaxone, ampicillin, vancomycin, and clinda-
mycin, respectively (Table 2).
Predicting factors of fatal outcome
Seventy of 82 patients (85.4%) fully recovered from
invasive S. agalactiae infection. The overall mortality
was 14.6% (12 patients). The patients who died had
bloodstream infection (n = 5), bloodstream infection
with meningitis (n = 3), arthritis (n = 2), urinary tract
infection (n = 1), and subcutaneous infection (n = 1),
respectively. The demographic data and clinical charac-
teristics of those 12 patients who died were shown in
Table 3.
Table 1 Demographic data and patient characteristics
Characteristics Urinary tract
infection
(N = 5)
Bloodstream
Infection
(N = 29)
Meningitis
1
(N = 8)
Arthritis
2
(N = 8)
Chorio-
amnionitis
(N = 10)
Subcutaneous
Abscess
(N = 19)
Male: female 3:2 16:13 7:1 3:5 0:12 1.2:1
Age (years) (median, IQR) 62 (57, 71) 51 (30, 68) 55.5 (31, 64) 52 (44, 62) 28 (24, 29) 53 (45, 63)
Signs/symptoms (N, %)
Fever (Body temperature ≥
38°C)
5 22 (75.9) 8 (100.0) 6 (75.0) 5 (41.7) 14 (73.7)
Headache 0 3 (10.3) 5 (62.5) 0 (0) 0 0
Arthritis 0 0 (0) 0 (0) 8 (100) 0 0 (0)
Alteration of consciousness 0 2 (6.9) 4 (50) 0 0 0
Laboratory findings (mean ± SD or median, IQR)
Hemoglobin (g/dL) 9.8 ± 2.4 12.6 ± 2.7 12.9 ± 2.3 11.6 ± 2.8 12.1 ± 1.6 11.9 ± 1.6
White blood cell count 7700 9800 10600 13900 13960 15500
(cells/mm
3) (6970, 9340) (8100, 14300) (8800,
11550)
(12600,
17180)
(10980, 14600) (12000, 23300)
Serum creatinine (mg/dL) 2.1 (1.0, 2.5) 1.1 (0.9, 1.4) 1.0 (0.9, 1.2) 1.4 (0.9, 2,2) - 1.4 (1.0, 1.9)
Death (N, %) 1 (20) 5 (17.2) 3 (37.5) 2 (25) 0 (0) 1 (5.3)
1 Included 5 patients who had bloodstream infection and meningitis, 1 patient who had bloodstream infection, meningitis, and arthritis, and 2 patients who had
isolated meningitis
2 Included 5 patients who had bloodstream infection and arthritis and 3 patients who had isolated arthritis
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and clinical characteristics between patients who sur-
vived vs. those who died. Univariate analysis revealed
that none of these variables was associated with
mortality.
Discussion
Streptococcus agalactiae is generally known to cause
invasive infection in pregnant women and neonates
since it commonly colonizes the vaginal and gastroin-
testinal tracts of healthy women[2]. However, infection
in non-pregnant adults has been increasingly reported
worldwide[5-8,10]. The incidence of invasive group B
streptococcal diseases in the United States significantly
i n c r e a s e df r o m3 . 4 / 1 0 00 0 0p o p u l a t i o ni n1 9 9 9t o5 . 0 /
100 000 population in 2005[10]. The same trend was
observed in Asia[6,8]. In our study, although the num-
ber of cases increased significantly from 2006 to 2007 (p
= 0.017, data not shown), the difference was not
observed from 2007 to 2009. However, we at least
demonstrated that there were 5 times more cases within
4y e a r sg i v e nt h es i m i l a rd iagnostic method and data
collection. This study also supports the evidence of
increasing number of patients who were not pregnant.
In addition, infections in non-pregnant adults occurred
in similar proportion in male and female that corre-
sponded to the previous studies [3,6,8,9]
Other reports have not noted seasonal variation. How-
ever, our study revealed that the number was higher in
September. We may need to further observe this phe-
nomenon and explore the explanation for this finding.
Sixty percent of infected patients had underlying med-
ical conditions including diabetes, chronic renal disease,
and malignancy. Diabetes was the most common under-
lying medical disease in previous reports [2,7,10] which
might be explained by the defect of bacterial engulfment
by the neutrophils[19].
Isolation of S. agalactiae from urine were mostly from
colonization; in our study, only 6.3% (5/79) of patients
with positive urine culture were determined as true
infection. This finding was similar to the report from
the United States that specimens from urine and vaginal
secretions were more likely to be colonization than
infection[4].
The most common site of S. agalactiae infection was
bloodstream infection which was also similar to other
reports [2,3,6,7,10]. However, a study from Greece
found that the most common site of infection was urin-
ary tract[5]. In that study, the authors stated that there
were two times more females than males, and it might
be possible that faecal contamination during urine col-
lection might have occurred[5]. Although echocardio-
gram was performed in all cases of bacteremia, no
endocarditis was found in our study.
Clinical data comparing to other studies is shown in
Table 5. Interestingly, in our study, meningitis was
found in higher proportion than in other reports
[3,6-8,10,11]. Seventy-five percent (6/8) of our patients
with meningitis had concurrent bloodstream infection.
The variation in infection sites among various reports
might be attributed to the serotype of S. agalactiae. S.
agalactiae is classified into serotype Ia/c, Ia/b, II, III, IV,
V, VI, VII, and VIII[20]. Bolanos M, et al found that
meningitis was correlated with infection with serotype
Ia, whereas bloodstream infection, skin and soft tissue
infections, urinary tract infection, and respiratory tract
infections were correlated with infection with serotype
III, V, III and V, and IV, respectively[21]. In addition,
serotypes vary by geographic regions, e.g., serotype Ia,
Ib, II, III, and V were accounted for 88% of adult cases
in the United States and the most common serotype
was serotype V[10]. In Japan, serotype Ia-V accounted
for 69% of adult cases, and the most common serotype
was serotype III[8]. This report also showed the viru-
lence of serotype VI, VII, and VIII, which were not com-
mon in the United States[8,10]. However, serotyping was
not performed in our study.
The mortality rate in our study was 15% while those
in other reports varied from 3 to over 30%[5,7-9,11].
Other reports found that mortality was associated with
bloodstream infection, hypotension, thrombocytopenia,
other concurrent bacterial infections, infection with ser-
otype Ia, and old age[2,3,7-10]. Although we found that
83.3% (10/12) of death occurred in patients who had
severe diseases, i.e., bloodstream infection and/or
meningitis, we failed to demonstrate this association in
the univariate analysis. In addition, we could not identify
other factors associated with mortality, which is prob-
ably due to the small sample size.
Table 2 Medical treatment of 82 patients infected with S.
agalactiae
Antibiotics Number of patients (%)
b-lactams
Penicillim G sodium 9 (11.0)
Ampicilin 12 (14.6)
Amoxicillin/clavulanic acid 1 (1.2)
Cloxacilin 3 (3.7)
Cefazolin 1 (1.2)
Ceftriaxone 40 (48.8)
Piperacillin/tazobactam 1 (1.2)
Meropenem 1 (1.2)
Imipenem 1 (1.2)
Other antimicrobial groups
Clindamycin 6 (7.3)
Vancomycin 6 (7.3)
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No. Sex Age
(years)
Site of
infection
Underlying
diseases
Signs/symptoms Laboratory findings Length of
hospital stay
(days)
White
blood
cells
(cells/
mm
3)
Platelets
(cells/
mm
3)
PTT
1
(seconds)
Creatinine
(mg/dL)
1 M 47 Bloodstream No Myalgia 8,400 97,000 34.1 3.2 1
2 M 47 Bloodstream No Myalgia, arthralgia 23,900 38,000 45.4 1.9 4
3 M 56 Bloodstream Chronic
alcohol
drinking
Myalgia, arthralgia 7,900 16,000 51.5 2.5 1
4 M 66 Bloodstream Chronic
alcohol
drinking
Fever, arthralgia, myalgia 3,800 47,000 92.3 1.2 1
5 M 68 Bloodstream No Fever 25,000 15,000 50.5 1.5 1
6 M 66 Bloodstream
and meningitis
CVA Fever, headache, stiffness of
neck
11,900 103,000 31.4 1.0 49
7 M 39 Bloodstream
and meningitis
HIV Fever, headache, stiffness of
neck, altered mentation
7,800 65,000 41.4 0.9 3
8 M 62 Bloodstream
and meningitis
Hematologic
malignancy
Fever, headache 12,700 25,000 - 1.1 48
9 F 50 Arthritis Chronic renal
failure, cancer
Arthritis 17,800 567,000 21.2 4.2 17
10 F 56 Arthritis No Arthritis 17,800 207,000 - 0.7 1
11 F 63 Urinary tract Renal stone Fever, dyspnea 9,340 14,000 53.4 2.1 150
12
2 M 59 Subcutaneous
abscess
Diabetes Fever, subcutaneous abscess 14,300 127,000 26.2 5.3 3
Abbreviation: PTT, partial thromboplastin time; CVA, cerebrovascular accident; HIV, human immunodeficiency virus
1 control range 24-34 seconds
2 concurrent Staphylococcus aureus bloodstream infection
Table 4 Comparison of demographic data and clinical characteristics between patients who survived vs. those who
died
Factors Survive (N = 70) Death (N = 12) p-value
Male (N, %) 33 (47.1) 9 (75.0) 0.074
Age (years) (median, IQR) 50 (28, 63) 59 (48.5, 64.5) 0.115
Underlying diseases (N, %)
Diabetes 16 (22.9) 1 (8.3) 0.275
Chronic renal diseases 9 (12.9) 1 (8.3) 0.661
Cirrhosis 1 (1.4) 1 (8.3) 0.206
Malignancy 6 (8.6) 2 (16.7) 0.791
Signs/symptoms (N, %)
Fever 54 (77.1) 8 (66.7) 0.438
Headache 5 (7.1) 3 (25.0) 0.071
Alteration of consciousness 6 (8.6) 1 (8.3) 0.978
Site of infection (N, %)
Bloodstream 24 (34.3) 5 (41.7) 0.621
Meningitis 5 (7.1) 3 (25.0) 0.054
Laboratory findings (mean ± SD or median, IQR)
Hemoglobin (g/dL) 12.1 ± 2.1 12.6 ± 3.4 0.486
White blood cell count (cells/mm
3) 12,700
(9800, 17100)
10,620
(7850, 15740)
0.213
Serum creatinine (mg/dL) 1.1 (0.9, 1.7) 1.6 (1.0, 2.8) 0.073
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lin, ampicillin, and vancomycin, which was similar to
other reports[5,22,23]. In general, group B streptococci
remain uniformly susceptible to penicillins and cepha-
losporins in vitro, and penicillin G is still the drug of
choice once the diagnosis is established[22]. However,
ceftriaxone was frequently used in our study due to
the fact that it could be administered once daily. Van-
comycin, an alternative choice in patients who are
allergic to b-lactams, was less frequently prescribed in
our study.
Conclusions
S. agalactiae infection is a growing problem in non-
pregnant patients, particularly in patients who had
underlying medical conditions. Physicians should con-
sider infection with S. agalactiae in the differential
diagnosis of patients with meningitis or septicemia. It
is noticeable from our study that no pregnant women
with S. agalactiae chorioamnionitis had life-threatening
conditions including bloodstream infection and menin-
gitis, whereas non-pregnant patients had more serious
infections; this might be explained by the fact
that pregnant women are younger and have less
comorbidities.
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